Encrypted login | home

Program Information

Optimal Time Release Schedule of In-Situ Drug Release During Permanent Prostate Brachytherapy

no image available
R Cormack

R Cormack1*, W Ngwa1 , S Tangutoori2 , K Rajiv2 , S Sridhar2 , G Makrigiorgos1 , (1) Dana-Farber Cancer Institute, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, (2) Northeastern University, Boston, MA,


SU-F-19A-8 Sunday 4:00PM - 6:00PM Room: 19A

Purpose:Permanent prostate brachytherapy spacers can be used to deliver sustained doses of radiosentitizing drug directly to the target, in order to enhance the radiation effect. Implantable nanoplatforms for chemo-radiation therapy (INCeRTs) have a maximum drug capacity and can be engineered to control the drug release schedule. The optimal schedule for sensitization during continuous low dose rate irradiation is unknown. This work studies the optimal release schedule of drug for both traditional sensitizers, and those that work by suppressing DNA repair processes.

Methods:Six brachytherapy treatment plans were used to model the anatomy, implant geometry and calculate the spatial distribution of radiation dose and drug concentrations for a range of drug diffusion parameters. Three state partial differential equations (cells healthy, damaged or dead) modeled the effect of continuous radiation (radiosensitivities α,β) and cellular repair (time tr) on a cell population. Radiosensitization was modeled as concentration dependent change in α,β or tr which with variable duration under the constraint of fixed total drug release. Average cell kill was used to measure effectiveness. Sensitization by means of both enhanced damage and reduced repair were studied.

Results:Optimal release duration is dependent on the concentration of radiosensitizer compared to the saturation concentration (csat) above which additional sensitization does not occur. Long duration drug release when enhancing α or β maximizes cell death when drug concentrations are generally over csat. Short term release is optimal for concentrations below saturation. Sensitization by suppressing repair has a similar though less distinct trend that is more affected by the radiation dose distribution.

Conclusion:Models of sustained local radiosensitization show potential to increase the effectiveness of radiation in permanent prostate brachytherapy. INCeRTs with high drug capacity produce the greatest benefit with drug release over weeks. If in-vivo drug concentrations are not able to approach saturation concentration, durations of days is optimal.

Funding Support, Disclosures, and Conflict of Interest: DOD 1R21CA16977501 A. David Mazzone Awards Program 2012PD164

Contact Email: